{"nctId":"NCT00125957","briefTitle":"The Effects of Wellbutrin (Bupropion) on Residual and Cognitive Symptoms in SSRI-treated Depression","startDateStruct":{"date":"2005-08"},"conditions":["Depression","Major Depressive Disorder","Unipolar Depression"],"count":32,"armGroups":[{"label":"Wellbutrin first, then Placebo","type":"EXPERIMENTAL","interventionNames":["Drug: Wellbutrin","Drug: Placebo"]},{"label":"Placebo first, then Wellbutrin","type":"EXPERIMENTAL","interventionNames":["Drug: Wellbutrin","Drug: Placebo"]}],"interventions":[{"name":"Wellbutrin","otherNames":["bupropion"]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Depression\n* SSRI-treated\n\nExclusion Criteria:\n\n* Bipolar disorder\n* Serotonin-norepinephrine reuptake inhibitor (SNRI) or bupropion treatment\n* Treatment-resistant depression\n* Seizure disorder\n* Bulimia or anorexia nervosa\n* Pregnancy","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"70 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Montgomery-Asberg Depression Rating Scale (MADRS)","description":"Median total depression symptoms rating at baseline and follow-up visits. The MADRS consists o 10 questions assessing depression symptoms. All questions are scored on a 0-6 severity scale, with 0 being absent and 4 being most severe. Total scores can range from 0-60.","paramType":"MEAN","dispersionType":"Full Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"22.0","spread":null},{"groupId":"OG001","value":"18.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"12.0","spread":null},{"groupId":"OG001","value":"14.0","spread":null}]}]}]},{"type":"PRIMARY","title":"Hamilton Depression Rating Scale (HAM-D)","description":"Median total depression ratings at baseline and follow-up using the HAM-D. The scale consists of 21 questions that assess depression symptoms. Questions 1-3, 7-11, 15, and 19 are rated on a scale of 0-4, with 0 being not present to and 4 being severe. Questions 4, 5, 12 - 14, 16-18 and 21 are rated from 0-2 with a score of 0 signifying the symptom is absent and a score of 2 as most severe. Item 20 is score on a scale of 0-3 with the same pattern of severity as all other questions. The total score for the HAM-D ranges from 0-63.","paramType":"MEDIAN","dispersionType":"Full Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"21.5","spread":null},{"groupId":"OG001","value":"14","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"13.5","spread":null},{"groupId":"OG001","value":"14","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":15},"commonTop":[]}}}